CCCC

C4 Therapeutics, Inc.

SEC CIK 1662579
$3.90 +106.3% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
10
Most recent
Advertisement

At a glance

Insiders at CCCC have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Crystal Adam sold $675K of CCCC, trimming their stake 100%.

Most active filer: Crystal Adam, with 10 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for CCCC, newest first
View on SEC EDGAR ↗
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Jan 5, 2022 ΔOwn −46%

Crystal Adam sold $440.5K of CCCC, trimming their stake 46%.

−$440.5K
13,946 sh @ $32
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Jan 5, 2022 ΔOwn −6.6%

Crystal Adam sold $34.4K of CCCC, trimming their stake 7%.

−$34.4K
1,054 sh @ $33
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Oct 5, 2021 ΔOwn −11%

Crystal Adam sold $75.8K of CCCC, trimming their stake 11%.

−$75.8K
1,712 sh @ $44
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Oct 5, 2021 ΔOwn −62%

Crystal Adam sold $370.6K of CCCC, trimming their stake 62%.

−$370.6K
8,176 sh @ $45
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Oct 5, 2021 ΔOwn −100%

Crystal Adam sold $235.1K of CCCC, trimming their stake 100%.

−$235.1K
5,112 sh @ $46
Advertisement
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Aug 2, 2021 ΔOwn −100%

Crystal Adam sold $675K of CCCC, trimming their stake 100%.

−$675K
15,000 sh @ $45
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Jul 6, 2021 ΔOwn −89%

Crystal Adam sold $504.4K of CCCC, trimming their stake 89%.

−$504.4K
13,300 sh @ $38
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Jul 6, 2021 ΔOwn −100%

Crystal Adam sold $65.2K of CCCC, trimming their stake 100%.

−$65.2K
1,700 sh @ $38
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Apr 6, 2021 ΔOwn −27%

Crystal Adam sold $153.1K of CCCC, trimming their stake 27%.

−$153.1K
4,121 sh @ $37
CCCC
Sell Crystal Adam · Chief Medical Officer · Open-market sale · filed Apr 6, 2021 ΔOwn −100%

Crystal Adam sold $413.4K of CCCC, trimming their stake 100%.

−$413.4K
10,879 sh @ $38
Advertisement

About CCCC insider activity

This page tracks every recent Form 4 filed for C4 Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is CCCC insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for C4 Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.